Viewing Study NCT01222767


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2026-01-01 @ 2:36 PM
Study NCT ID: NCT01222767
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 2010-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
Sponsor: PharmaMar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ewing's Sarcoma View
None Primitive Neuroectodermal Tumor (PNET) View
None Askin's Tumor of the Chest Wall View
None Extraosseous Ewing's Sarcoma (EOE) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EFT View
None PNET View
None EOE View